Queensland COVID-19 research
This page of Queensland’s research related to the COVID-19 pandemic is compiled from information provided by Queensland universities and research institutes.
While many of our researchers are working on potential vaccines, treatments and other medical interventions, other researchers are applying their expertise to other impacts of the pandemic upon our economy and other aspects of society. The data includes immediate research activity, recent relevant work, proposed research (subject to available funds) and other responses using the resources and expertise of our research organisations.
Listing 1 matching response out of 149 total responses.
Using multidisciplinary approaches to identify compounds that bind to Human ACE2 or SARS-CoV-2 Spike Protein as candidates to block SARS-CoV-2-ACE2 Receptor interactions. March 2021
A team of leading researchers at Griffith University’s Institute of Glycomics used multidisciplinary approaches to identify compounds that bind to Human ACE2 or SARS-CoV-2 Spike Protein as candidates to block SARS-CoV-2-ACE2 Receptor interactions. This study has identified potential drugs for repurposing as SARS-CoV-2 entry inhibitors or as chemical scaffolds for drug development and is published at American Society for Micobiology mBio Journal.
Institute for Glycomics
- Contact details
- Prof Michael Jennings
Deputy Director and NHMRC Principal Research Fellow
Other Queensland COVID-19 initiatives
- Queensland Government
- Coronavirus (COVID-19) business assistance finder
- Life Sciences Queensland
- Life Sciences Queensland joins the data-powered alliance to stop COVID-19
Key Australian COVID-19 initiatives
Key international COVID-19 initiatives
- CORD-19 (COVID-19 Open Research Dataset)
- Free database of 130,000 plus COVID-19 open research papers